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I. INTRODUCTION 
A. Review of ADP-ribosylatlon 
The role of posttranslatlonal modification of proteins in the 
regulation of biological processes has been extensively studied. 
Some of the modifications most thoroughly studied include acetylation, 
methylation, and phosphorylation. ADP-ribosylatlon is another type of 
covalent modification whose role in the regulation of cellular metabolism 
is yet to be understood. 
ADP-ribosylatlon Involves the transfer of an ADP-ribose group from 
NAD to an acceptor protein (Figure 1). There are two types of 
ADP-ribosylatlon reactions that may occur within a cell. The first type, 
known as poly-ADP-ribosylation, occurs primarily in the nucleus (1). 
Poly-ADP-ribose synthetase (EC-2.4.2.30) is responsible for the transfer 
of a series of ADP-ribose units to histones and other nuclear proteins 
resulting in a polymeric chain of ADP-ribose units (2). The existence of 
a poly-ADP-rlbose glycohydrolase enzyme (3,4), along with reports of 
Increased ADP-ribosyl transferase activity during cell proliferation (5), 
differentiation (6-9), transformation (10) and DNA repair (11-14) 
supports the role of poly-ADP-rlbosylation as a regulator of cellular 
metabolism. 
The second type of ADP-ribosylatlon reaction involves the transfer 
of a single ADP-ribose unit to an acceptor protein and is therefore known 
as mono-ADP-ribosylatlon. Mono-ADP-ribosylatlon has been reported in a 
wide variety of cellular systems. Bacterial toxins such as cholera toxin 
Figure 1. ADP-ribosylation reaction scheme with LAME as the acceptor 
0 O 
CHj-O-'p-O-f—O-CH.'i! 1 IY"''3 
im ÀH W + NHg-CH-g 
C=NH 
r 
(CH2)3 
HO OH HO OH 
NAD* 
C -g-O-CHj 
LAME 
ENZYME 
ADP-Ribose 
O NH 
ÛT""' + 
Î=NH 
NH 
(^"2)3 
NICOTINAMIDE NH^cH-C-O-CH, 
A DP -Ribosyiated 
LAME 
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(15,16), E. coll LT enterotoxin (17), diphtheria toxin (18), and pertussis 
toxin (19) elicit their pathogenicity by ADP-ribosylating target proteins 
in infected cells. Mono-ADP-ribosyl transferase activity has also been 
reported in lower eukaryotes such as slime molds (20) and upper 
eukaryotes including avian and human erythrocytes (21,22), rat and 
chicken liver (23,24) Xenopus tissues (25), canine kidney (26), bovine 
thyroid (27), and rabbit skeletal muscle (28,29). The widespread 
occurrence of the transferases has attracted the Interest of many 
research groups who are trying to understand the role that the 
mono-ADP-ribosyl transferase plays in the regulation of cellular 
metabolism. 
Kharadia and Graves have shown that ADP-ribosylation of Kemptide, a 
synthetic peptide, suppresses its ability to be phosphorylated by 
cAMF-dependent protein kinase (30). The relationship between 
phosphorylation and ADP-ribosylation has also been investigated by 
Tanigawa and associates. They have shown that ADP-ribosylation 
suppresses the ability of cAHP-dependent protein kinase to phosphorylate 
histones and phosphorylase kinase (31). Other metabolic pathways which 
have been shown to be affected by mono-ADP-ribosylation include: 
stimulation of thyroid cells by thyrotropin (32), isoproterenol 
n É 
stimulation of hepatocytes (33), and Ca release in mitochondria (34). 
The existence of hydrolases which specifically cleave ADP-ribose 
from mono-ADP-ribosylated substrates has also been reported. Hydrolase 
activity has been described in turkey erythrocytes (35,36), in the 
photosynthetic nitrogen-fixing bacterium Rhodosplrillum rubrum (37), and 
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in skeletal muscle (38,39); all of which also possess endogenous 
transferase activity. These reports point strongly toward a highly 
regulated pathway which utilizes the reversible mono-ADP-ribose 
modification and its possible interaction with phosphorylation-
dephosphorylation pathways. 
The specificity of mono-ADP-ribosyltransferases has also been 
studied. There are three general types of mono-ADP-ribosyl transferases 
based on the amino acid that is modified on the acceptor substrate. An 
example of the first type is diphtheria toxin. Diphtheria toxin 
ADP-ribosylates elongation factor-2 at a diphthamide residue resulting in 
its Inactivation and ultimately cell death (18). Diphthamide is a unique 
amino acid related to histidine. The second type of mono-ADP-ribosyl 
transferase specifically modifies cysteine residues. An example of this 
. type is pertussis toxin. Pertussis toxin ADP-ribosylates a cysteine 
residue on the GTF-binding protein which results in irreversible 
activation of adenylate cyclase (40). The third type of transferase is 
represented by cholera toxin which ADP-ribosylates an arginine residue on 
another OTP-binding protein, Gg (41). Although cholera and pertussis 
modify two different G proteins, the net effect is the same. The 
irreversible activation of adenylate cyclase results in an outpouring 
of ions and water from the cell, also known as diarrhea (15,16). 
B. Previous Assays Used 
The natural substrates for the endogenous mono-ADP-ribosyl 
transferases have not been determined. However, the transferases have 
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been shown to utilize many small molecular weight compounds as artificial 
substrates. The remainder of this study will be concerned with the assay 
of arginine specific mono-AOP-ribosyl transferases such as cholera toxin 
and the transferase found in rabbit skeletal muscle. 
ADP-ribosyl transferase activity has been assayed using substrates 
such as [a-^^P]NAD (42), [adenineNAD (23,27), or [carbonyl-]NAD 
(16). The incorporation of radioactive ADP-ribose or the release of 
radioactive nicotinamide was followed by separation of the reaction 
mixture on a low performance ion-exchange column. However, it has been 
shown by several groups that the transferases are also capable of 
hydrolyzing the NAD to free nicotinamide and ADP-ribose in the presence 
or absence of an acceptor substrate (16,21,23). Therefore, the 
experiments had to be run in duplicate with and without acceptor so the 
rate of NAD hydrolysis could be accounted for when the free nicotinamide 
was measured. 
Other studies have utilized specially synthesized model substrates. 
125 Mekalanos and co-workers used I-guanyltyramine as a low molecular 
weight acceptor (43). Again, the radioactivity was followed after 
separation of the product from the unreacted radiolabelled guanyltyramine 
on a low performance.anion exchange column. Soman and associates have 
synthesized non-radioactive substituted (benzylidineamino) guanidine 
compounds which absorb light in the UV and visible regions (44,45). The 
products were separated from the substrates on a reversed-phase HPLC 
column. Unfortunately, the solubility of these compounds is somewhat low 
which has limited their usefulness in determining the kinetic parameters 
7 
of arglnlne specific transferases (46). 
Arglnlne containing peptides have been used by Kharadla and Graves 
for specificity studies. They have shown that small molecular weight 
substrates which contain a primary amine are also chemically 
ADP-ribosylated at a site other than the guanidino group (30). 
Presumably, this occurs through a schlff base type reaction between the 
primary amine and the free ADP-rlbose formed from the hydrolase reaction. 
The separation and detection scheme must be able to differentiate between 
the enzymatic and nonenzymatlcally derived product when using a 
substrate which contains both a primary amine and the guanidino group. 
C. High Performance Liquid Chromatographic Enzyme Assays 
A sensitive assay system is required when studying an enzyme. The 
first enzyme assays utilized the property that the products of enzyme 
reactions often have different absorbance spectra than the substrates. 
Dehydrogenases are a good example of this type of system. The UV 
spectrum of NADH is markedly different than that of the substrate NAD 
(47,48). However, some enzymes, such as the kinases which utilize ATP and 
form ADP, cannot be followed by a simple spectroscopic assay because the 
absorbance spectra of the two adenine containing compounds are so 
similar. This problem has been overcome by coupling the assay to another 
enzyme system in which the product of the kinase reaction serves as a 
substrate for the dehydrogenase reaction (49). When direct or coupled 
spectroscopic techniques could not be used, the method most often used 
was radioactive labeling of one of the substrates. However, many of the 
8 
radioactive assays employed some type of a time-consuming low performance 
chromatography step to isolate the product of interest. Examples of 
these are given earlier in this introduction (16, 23,27 42,43). 
Recently, a number of vendors have introduced new bio-compatible 
HPLC systems which are designed especially for the separation of proteins 
and peptides and their metabolites (50,51). This fact, along with the 
advent of more user friendly instrumentation, are the two main reasons 
that HPLC enzyme assays have become widely used throughout the field of 
Biochemistry. Literally hundreds of enzymes have been assayed by HPLC 
methods including those involved in the metabolism of amino acids, 
carbohydrates, nucleotides, peptides, and proteins (52,53). 
One of the advantages of HPLC is that it enables the researcher to 
follow the changes in concentration of several components of the reaction 
mixture simultaneously. The components are first separated 
chromatographically on the column and then detected on-line. Substrate-
product pairs which have similar absorbance spectra may then be studied by 
HPLC without coupling the assay to another system. Development of new 
stationary phases with improved separation efficiencies has allowed for 
the detection of enzyme activity in the presence of other enzymes. This 
eliminates the need for excessive purification before an enzyme may be 
thoroughly studied. Separation of radioactive components may also be 
done on a more efficient time scale using HPLC rather than a low 
performance technique. 
Another advantage of using an HPLC assay is that it lends Itself 
readily to a number of different on-line detection schemes. These 
9 
Include: UV and visible absorption, fluorometry, circular dlchrolsm, 
refractive Index, scintillation counting and various electrochemical 
methods (54). Thus, HPLC is nearly a universal method for the detection 
of enzyme activities. 
A number of reviews have been written on the use of HPLC in 
developing enzyme assays (52,55). Sloan has written one which 
specifically covers the use of HPLC for kinetic analysis (53). It is 
with these resources and those previously mentioned in this introduction 
that we embarked on our study of the kinetic mechanism of arginlne 
specific ADP-ribosyl transferases. 
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II. OBJECTIVES 
The objectives of this study were: 1) to develop an assay for 
arginine specific ADP-ribosyl transferases and 2) to use that assay for 
the determination of the kinetic mechanism of the transferases. The 
assay does not require a specially synthesized substrate but rather one 
that is commercially available in a highly purified form and fairly 
inexpensive. We did not want to use radiolabelled substrates 
because of the hazards associated with handling them. An HPLC method was 
chosen so that we could follow many reaction components simultaneously If 
we so desired. Another advantage of an HPLC method was rapid sample 
throughput, as literally hundreds of samples would be analyzed before the 
study was concluded. For these reasons we chose an assay based on 
derivatization with a fluorescent tag (ortho-phthaldialdehyde), followed 
by separation of the mixture on a reversed-phase HPLC column. 
Ortho-phthaldialdehyde/2-mercaptoethanol reagent has been primarily 
used to form fluorescent derivatives with amino acids (56). However, the 
only requirements for derivatization are the presence of a primary amine 
and a sulfhydryl agent to form a highly fluorescent isoindole derivative 
(Figure 2). Derivatization of polar amino acids with 
OPA/2-mercaptoethanol reagent, prior to injection, allowed them to be 
separated very efficiently on a reversed-phase column. Unreacted OPA did 
not interfere with the assay because it did not fluoresce. Figure 3 
shows the separation of 22 physiological amino acids in less than 25 
minutes. The same mixture would require 60-90 minutes to obtain a 
Figure 2. OFA reaction scheme. Reaction goes to completion In 1-2 
minutes at room temperature 
S-R 
N—R + HpO 
mm. 
U+RNHj + R<SH 
highly fluorescent 
non—fluorescent 
o—phthaldialdehyde isoindole 
to 
Figure 3. Chromatogram of OPA derlvatlzed amino acids. A mixture of 
22 physiological amino acids was mixed with an equal volume of 
OPA/2-mercaptoethanol reagent for 1 minute at room 
temperature. The mixture was injected onto a C-8 column at a 
flow rate of 1.5 ml/min. A gradient elution program of 5% to 
65% fi in 25 minutes was used to resolve the mixture. The 
composition of buffers A and B can be found under Methods 
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satisfactory separation on an ion exchange column. 
It has been shown that the arginine specific ADP-ribose linkage is 
a-N-linked through the guanidino side chain of arginine (57,58). Moss 
(15,21), Soman (44,45), Mekalanos (43) and their co-workers have shown 
that small molecular weight guanidino compounds, including arginine and 
arginine methyl ester, could be utilized as ADP-ribose acceptors in the 
transferase reaction. We used L-arginine methyl ester as the acceptor 
substrate in our studies utilizing the free amino group as the site of 
derivatization with OPÂ. If the primary amine group on LAME was 
chemically AOP-ribosylated, it would not be derlvatized by the OPA/2-
mercaptoethanol reagent and, therefore, would not detected by the 
fluorescence detector. This property alone obviates the need to run 
controls for nonspecific chemical ADP-rlbosylation reactions such as 
those observed by Kharadia and Graves (30). 
Cholera Toxin A subunit was used as the arginine specific ADP-ribosyl 
transferase in the development of the assay. This enzyme has been well 
characterized (43,59,60,61) and was available commercially in a purified, 
stable and relatively nontoxic form. 
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III. HATERIALS AND METHODS 
A. Materials Used 
Cholera Toxin A subunit, NAD, 3-aminobenzamide, L-arginlne methyl 
ester and dithiothreitol were purchased from Sigma (St. Louis, MO). 
N^ -monomethylarglnine was from Calblochem (San Diego, CA). 
OFÀ/2-mercaptoethanol reagent was from Pierce (Rockford, XL). OPA-HR 
C-8 reversed-phase column was from Alltech (Deerfleld, IL). Vydac 301TP 
anion exchange column was from Anspec (Ann Arbor, MI). HPLC grade 
tetrahydrofuran, methanol and potassium phosphate buffer salts were 
from Fisher (Springfield, NJ). All water used for buffer preparations, 
reagent dilution, and HPLC solvent dilution was delonlzed to 18 megaohm 
using a Milli-Q water system from Millipore (Bedford, MA). 
B. Methods 
1. Purification of rabbit skeletal muscle transferase 
The purification of rabbit skeletal muscle transferase was as 
previously described by Peterson et al.(29). Fractions obtained from the 
Con A elution step were used in all the muscle transferase assays with at 
least a ten-fold dilution unless otherwise specified. 
2. ADP-rlbosvl transferase assay 
The ADP-rlbosyl transferase assay mixture for cholera toxin contained 
50 mM potassium phosphate of pH 7.0, 20 mM DTT, and various amounts of 
NAD and LAME as indicated. The reaction was initiated with substrate 
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and incubated at 30°C. Cholera toxin (25 ug/ml) was preactivated for 45 
minutes at 30°C in the phosphate-DTT mixture. 
The ADP-ribosyl transferase assay mixture for the rabbit skeletal 
muscle enzyme contained 50 mM potassium phosphate of pH 7.0 and various 
amounts of NAD and LAME as indicated. The reaction was initiated with 
enzyme (550 units/ml) and Incubated at 30°C. In all assays, the 
reactions were stopped by pipetting an aliquot of the assay mixture into 
an equal volume of ice cold 10% TCA and diluted with DI water when 
necessary. Samples were stable up to two weeks when stored at 4°C. 
3. opA derivetisatipn and HPLÇ Analysis 
The HPLC system consisted of two model llOA pumps and a 421 gradient 
programmer (Beckman; Berkeley, CA). Solvent A was 50 mM potassium 
phosphate of pH 4.0. Solvent B was 5% THF + 95% methanol. The sample to 
be analyzed was derivatized with 25 ul of OPA/2-mercaptoethanol reagent 
for 1 minute and injected onto a 10 cm C-8 reversed-phase column at a 
flow rate of 1.5 ml/min. The gradient conditions were 5% to 100% B In 5 
minutes starting at the time of injection. Total analysis time for each 
sample was 15 minutes. ADP-rlbosylated-LAME had a retention time of 3.9 
minutes. Fluorescence was monitored with a Kratos FS 950 fluorometer 
(ABI; Ramsey, NJ) equipped with a 365 nm bandpass excitation filter and a 
418 nm cutoff emission filter. 
4. Purification and characterization of product peak 
A 24 hour incubation of a cholera toxin mixture was diluted 1:1 with 
10% TCA. An aliquot of 200 ul was then Injected onto a 25 cm Vydac anion 
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exchange column. The mixture was eluted Isocratlcally with 50 mM 
phosphate buffer of pH 2.5. Elutlon was monitored at 260 nm with a 
Kratos Spectroflow 757 UV-Vls spectrophotometer (ÂBI; Ramsey, NJ). The 
260 nm absorbing peaks were then analyzed by OPA derlvatlzatlon for 
content of the suspected product peak. An absorbance wavelength spectrum 
was taken of the anion exchange peak which contained the ADF-ribosylated-
LAME. The molar absorptivity of ADP-ribose at 260 nm (1500 cm"^  M'^ ) was 
used to calculate the concentration of the ADP-ribosylated-LAME in the 
mixture. This concentration was then used to calculate the limit of 
detection of the assay. 
5. Kinetic assavs 
Initial velocities were determined as a function of varied substrate 
concentration at several different fixed levels of the second substrate 
by measuring the amount of product formed over a given time. Time course 
studies were performed using the highest and lowest substrate 
concentrations to Insure that the velocities were measured in the linear 
region. Llneweaver-Burk plots were constructed to determine the kinetic 
parameters. A computer modeling program, developed by Viola (62), 
that fit the raw data to equations describing various mechanisms was also 
used to evaluate the kinetic parameters. Inhibitor studies were 
performed by adding various amounts of 3-amlnobenzamide or 
N^ -monomethylarginine with the substrates when initiating the reactions. 
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IV. RESULTS AND DISCUSSION 
A. Validation of Assay 
Cholera toxin A subunit was used as the arginine specific 
ADP-ribosyl transferase in the development of the assay. The toxin was 
purchased in a highly purified form to eliminate the possibility of 
interfering enzymatic activities during the initial stages of assay 
development. Figure 4 shows a chromatogram obtained from a 1 hour 
incubation of LAME with cholera toxin. The absence of a peak with a 
retention time of 3.9 minutes in the zero time (a) and 1 hour control (c) 
samples indicated that this peak was a product of the cholera toxin 
reaction. The only products produced in the ADP-ribosylation of LAME by 
cholera toxin are ADP-ribosylated-LAME and nicotinamide. Since 
nicotinamide does not contain a primary amine, it could not be 
derivatized by the OPA/2-mercaptoethanol reagent. Therefore, the only 
product that could be detected was ADP-ribosylated-LAME. 
The appearance of the product was found to be linear with time up to 
5 hours as shown in Figure 5. In all stages of the assay development, 
control reactions were run in which the enzyme or one of the substrates 
was omitted. This confirmed that the new peak was indeed a product of 
the enzyme reaction and not simply a breakdown product from one of the 
components in the reaction mixture. 
Purification of the product peak was required before further 
characterization studies could be attempted. Figure 6a shows the 
chromatogram obtained from the injection of a 24 hour cholera toxin assay 
Figure 4. Chromatograns of OPA derivatlzed samples from cholera toxin 
reactions and control mixtures. An aliquot of the cholera 
toxin assay mixture was mixed with an equal volume of 
OPA/2-mercaptoethanol for 1 minute at room temperature. The 
mixture was injected onto a C-8 column at a flow rate of 
1.5 ml/min. Elution conditions are described in Methods. 
Panel a shows the chromatogram from a zero time point sample. 
Panels b and c are 1 hour time points of cholera toxin 
reaction mixtures with (b) and without (c) LAME 
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Figure 5. Time course plot. Cholera toxin (25 ug/ml) was preactivated 
with DTT as described under Methods. The ADP-ribosylation 
reaction mixture contained 20 mM DTT, 50 mM LAME, 2 mM NAD, 
50 mM potassium phosphate at pH 7.0 and incubated at 30 °C. 
Aliquots were removed at various times and the reaction was 
stopped by the addition of an equal volume of ice cold 10% 
TCA. Samples were derivatized with an equal volume of 0PÂ/2-
mercaptoethanol reagent and injected onto the HPLC system as 
previously described. The height of the product peak was 
plotted versus the time at which the reaction was stopped. 
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mixture onto an anion exchange column. Peaks A,B,G, and D absorbed 
strongly at 260 nm, a wavelength near the maximum absorbance of 
ADP-ribose. Repeated injections were made and the four separate 
fractions were collected and pooled. An aliquot of each of the pooled 
samples was analyzed by OPA/2-mercaptoethanol dérivâtization to determine 
which one contained the product of interest. Pool A contained the 
majority of the product as shown in Figure 6b. Further purification of 
the product was obtained by reinjecting the pooled A fraction onto the 
anion exchange column. Spectral analysis of peak A was used to determine 
the concentration of ADP-ribosylated-LAHE by using the extinction 
coefficient of ADP-ribose at 266 nm. The absorbance spectrum of peak A 
is shown in Figure 7. Background absorbance was subtracted by scanning a 
blank which contained the anion exchange eluant. The concentration of 
ADP-ribosylated-LAME was also determined using acid hydrolysis to release 
the ADP-ribose moiety, followed by amino acid analysis. The 
concentration of LAME determined by this method agreed with the 
calculated concentration of ADP-ribose within +5%. The average of these 
two values was used as the concentration of ADP-ribosylated-LAME in the 
standard sample. 
An enzyme assay should be able to detect the formation of product in 
a reaction mixture at very low levels, especially if the assay will be 
used to monitor the purification of an enzyme. Many enzymes are present 
at very low levels in vivo which makes them quite difficult to detect in 
the initial purification fractions. Fluorescence methods provide low 
limits of detection due to low levels of background noise. Figure 8 
Figure 6. Anion exchange separation of cholera toxin reaction mixture 
and OPA derivatization of peak A. A reaction mixture 
containing 25 ug/ml cholera toxin a subunit, 20 nM DTT 
50 mH LAME, 5 mH NAD, and SO mM potassium phosphate at pH 7.0 
was incubated at 30 °C for 24 hours. An aliquot of the 
reaction mixture which was diluted 1:1 with 10% TCA was 
injected onto an anion exchange column. The sample was 
eluted isocratically with a 50 mH phosphate buffer of pH 2.5. 
Absorption was monitored at 260 nm (panel a). Peaks A-D were 
collected separately and analyzed by OPA derivatization with 
HFLC analysis as described earlier. Panel b shows the 
chromatogram obtained upon injection of an OPA dérivâtIzed 
sample of peak A. 
ABSORBANCE 260 nm 
Figure 7. Absorbance spectrum of peak A. The absorbance spectrum of 
the reinjected peak A was measured from 200 to 400 nm. A 
sample of the anion exchange eluant was used to set the blank 
before obtaining the spectrum of peak A. The absorbance at 
266 nm was used to calculate the concentration of 
ADP-ribosylated-LAME In the sample 
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shows the chromatogram obtained upon injection of 600 femtomoles of ADF-
ribosylated-LAME, resulting in a limit of detection of 300 femtomoles at 
a signal to noise ratio of 3. This highly sensitive assay lends itself 
readily to samples containing very small amounts of arginine specific 
ADP-ribosyl transferase. 
Recently, Peterson and co-workers used the assay in the purification 
of a transferase from rabbit skeletal muscle (29). This confirmed the 
ruggedness and adaptability of the assay. Dilution studies proved that 
the assay was linear with total protein concentration ranging from 0.2 to 
2.0 mg/ml, as shown in Figure 9. It could be used from the very first 
step in the purification, which contained dozens of enzymes, right 
through to the final affinity chromatography step. Table 1 lists the 
various steps carried out in the purification of the rabbit muscle 
enzyme. There was also no apparent interference from detergents used to 
solubilize the enzyme which is a common problem with UV or visible 
absorbance techniques. 
The DEÀ-BAG assay, which was developed by Soman and associates 
(44,45), was previously used to determine the transferase activity. 
However, it was unable to detect the transferase activity in the final 
affinity purification step. The turnaround time for the HPLC DEA-BAG 
assay was approximately 35 minutes. The CPA assay has cut the turnaround 
time by more than one half, to 15 minutes, allowing for the analysis of 
more than twice as many samples in the same amount of time. Another 
advantage of the CPA assay system is the use of a gradient elution 
program. The DEA-BAG assay uses isocratic elution which creates the 
Figure 8. Chromatogram showing the limit of detection. 600 femtomoles 
of ADP-rlbosylated-LAME was derlvatlzed with 25 ul of OPA/2-
mercaptoethanol reagent and chromatographed under the 
conditions described in Methods. The arrow points to the 
product peak which gives a signal to noise ratio of 6. This 
resulted in a limit of detection of 300 femtomoles at a 
signal to noise ratio of 3 
Fluorescence Intensity 
Figure 9. Linear dilution studies. Samples from the 100 k x g 
supernatant obtained in the purification of rabbit skeletal 
muscle transferase were diluted to give total protein 
concentrations ranging from 0.2 to 2.0 mg/ml in the assay 
mixture. They were incubated with 25 nM LAME, 10 mM NAD, and 
50 mM potassium phosphate (pH 7.0) at 30 °C for 120 minutes. 
The reactions were stopped with an equal volume of ice cold 
10% TCA and derivatized with OPA as previously described. 
Peak heights of ADP-ribosylated-LAHE obtained from the 
reversed phase HPLC analysis were plotted versus total 
protein in the reaction mixture 
I l  
33 
4.00 -
.00 
o> 
2.00 
1.00 
Q. 
0.00 ÔÔSÔ 0.0V5 0.000 0.025 0.125 0.100 
Protein (mg/ml) 
60.0 -
40.0 -
o> 
"o 20.0 -q> 
Q. 
0.0 ôiô 230 0.00 
Protein (mg/ml) 
34 
Table 1. Summary of the purification of rabbit skeletal muscle 
transferase* 
Purification Step Protein Concentration 
(mg/ml) 
Specific Activity 
(units/mg) 
15 k X gO 
supernatant 
100 k X £ 
supernatant 
Deoxycholate 
soluble fraction 
DE-52 pool 
Con A eluate 
3-ABA eluate 
12.8 
11.0 
6 . 0  
0 .26 
0.54 
0.01 
11.5 
200 
294 
1160 
15900 
27400 
A^dapted from reference 29. 
"^k X g" - 1000 times the force of gravity. 
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possibility that late elutlng peaks will interfere with subsequent 
injections. By using a gradient program the column is flushed of all 
components before the next sample is injected. 
B. Determination of Kinetic Parameters 
Once the validity of the assay was proved, we were able to proceed 
with the kinetic portion of the study. The kinetic mechanism of cholera 
toxin has been studied by a number of investigators. Mekalanos et al. 
reported an ordered sequential mechanism with values for NAD and 
-guanyltyramine of 3.6 mM and 44 uM, respectively (43). Their 
arguments were not very convincing, however, as their double reciprocal 
plots did not Intersect in the same quadrant. Osborne, Stanley, and Moss 
reported a rapid equilibrium random sequential mechanism for both cholera 
toxin and the avian erythrocyte enzymes using agmatlne as the acceptor 
substrate (63). However, l/[agmatine] vs. 1/v plots were not shown for 
reasons that were not stated in the manuscript. 
Our results also supported a sequential mechanism for cholera toxin. 
The Llneweaver-Burk plots, shown in Figures 10 and 11, resulted in a 
pattern of nonparallel lines which Intersected at one common point In the 
lower left quadrant. This type of intersection pattern is indicative of 
a sequential rather than a ping pong type mechanism. The two different 
mechanisms are Illustrated in Figures 12 and 13 (64). Figure 12 
represents the sequential mechanism where both substrates must bind to 
the enzyme before any product is produced. However, as shown in Figure 
13, a ping pong mechanism is one where the first substrate binds and a 
Figure 10. Double reciprocal plot of initial velocity versus LAME 
concentration at constant NAD concentrations using cholera 
toxin. The reciprocal of the initial velocities at various 
constant levels of NAD were plotted as a function of the 
reciprocal of LAME concentration. The incubation mixtures 
contained 25 ug/ml of activated cholera toxin, 50 nM 
potassium phosphate pH 7.0, 20 mM DTT, and LAME. NAD 
concentrations were: g 0.75 mM, A 1.5 mM, ^  3.0 mM, ^  6.0 mM 
pmole -mm 
AE 
Figure 11. Double reciprocal plot of initial velocity versus NAD 
concentration at constant LAME concentrations using cholera 
toxin. The reciprocal of the initial velocities at various 
constant levels of LAME were plotted as a function of the 
reciprocal of NAD concentration. The incubation mixtures 
contained 25 ug/ml of activated cholera toxin, 50 mtl 
potassium phosphate pH 7.0, 20 nM DTT, and NAD. The LAME 
concentrations were: # 10 mM, # 15 oM, A 20mM, tIrSO nM 
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Figure 12. Sequential mechanism scheme. This is a scheme representing 
a sequential mechanism Involving an enzyme (E), two 
substrates (A and B), and two products (P and Q). Adapted 
from reference 64 
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Figure 13. Ping Pong mechanism scheme. This scheme represents a ping 
pong mechanism involving an enzyme (E), two substrates 
(A and B), and two products (P and Q). Adapted from 
reference 64 
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product is formed, before the second substrate binds. 
The same type of experiments were performed using a preparation of 
the rabbit skeletal muscle transferase. In these assays the fraction 
obtained from the Con A affinity step was used. This fraction was 
shown to contain over 50% transferase with relatively few remaining 
proteins (29). The final 3-ABA affinity fraction was not used because of 
the extremely low yield of enzyme. As shown in Figures 14 and 15, double 
reciprocal plots .for this enzyme also showed a pattern indicative of a 
sequential mechanism. The linear nature of the Lineweaver-Burk plots, 
obtained with cholera toxin and the rabbit skeletal muscle enzyme, 
indicates that they both obey Michaelis-Menten type kinetics. 
The secondary plots constructed from the slopes and intercepts of 
the Lineweaver-Burk plots are shown in Figures 16-19. Figures 16 and 17 
show the secondary plots obtained when using cholera toxin. The 
secondary plots obtained when using the rabbit skeletal muscle 
transferase are shown in Figures 18 and 19. The intersection point of 
the lines with the abscissa on the intercept plots give the Michaelis 
constant of the substrate at infinite concentration of the other 
substrate. The maximal velocity in the forward direction, at infinite 
concentration of both substrates, is calculated from the intersection 
point on the ordinate of the intercept plot. The same parameters may 
also be obtained from the slope plots. The kinetic parameters calculated 
from these plots were compared and averaged with those obtained from the 
computer modeling program (62). The formulae of the rate equations used 
for the calculation of these results are found in the Appendix. 
Figure 14. Double reciprocal plot of initial velocity versus LAME 
concentration at constant NAD concentrations using rabbit 
skeletal muscle transferase. The reciprocal of the initial 
velocities at various constant levels of NAD were plotted as 
a function of reciprocal of LAME concentration. The 
incubation mixtures contained 5 ug/ml rabbit muscle 
transferase (Con A fraction), 50 mit potassium phosphate pH 
7.0, and LAME. The concentrations of NAD were: ^  25 uM, 
• 50 uM, A 75 uM, # 100 uM 
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Figure 15. Double reciprocal plot of Initial velocity versus NAD 
concentration at constant LAME concentrations using rabbit 
skeletal muscle transferase. The reciprocal of the initial 
velocities at various constant levels of LAME were plotted as 
a function of NAD concentration. The incubation mixture 
contained 5 ug/ml of rabbit muscle transferase (Con A 
fraction), 50 mM potassium phosphate, and NAD. The LAME 
concentrations were: # 0.25 mM, # 0.75 mM, 3#^ 1.0 mM, As.O mM 
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Figure 16. Secondary slope plots for cholera toxin. Slopes of the 
family of lines in Figures 10 were plotted versus the 
reciprocal of NAD concentration (a) and slopes of the family 
of lines in Figure 11 were plotted versus the reciprocal of 
LAME concentration (b) 
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Figure 17. Secondary intercept plots for cholera toxin. Intercepts with 
the 1/v axis of Figure 10 were plotted versus the reciprocal 
of NAD concentration (a) and intercepts with the 1/v axis of 
Figure 11 were plotted versus the reciprocal of LAME 
concentration 
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Figure 18. Secondary slope plots for rabbit skeletal muscle transferase. 
Slopes of the family of lines in Figure 14 were plotted as a 
function of the reciprocal of NAD concentration (a) and 
slopes of the family of lines in Figure 15 were plotted as a 
function of the reciprocal of LAME concentration (b) 
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Figure 19. Secondary Intercept plots for rabbit skeletal muscle 
transferase. Intercepts with the 1/v axis of Figure 14 were 
plotted as a function of the reciprocal NAD concentration (a) 
intercepts with the 1/v axis of Figure 15 were plotted as a 
function of the reciprocal LAME concentration (b) 
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the values of kinetic parameters for cholera toxin, determined by 
various investigators, are listed in Table 2. Our results for cholera 
toxin, of 5.6 mM for NAD and 39 mM for LAME, agree very well with those 
also corresponds rather closely to that obtained by other groups. The 
endogenous rabbit muscle transferase resulted in values which were 
somewhat higher than those reported by Osborne for the avian erythrocyte 
enzyme as shown in Table 3. This difference is most likely due to the 
fact that the avian transferase was obtained from the soluble cell 
fraction, whereas, the rabbit transferase was isolated from the membrane 
fraction. The soluble and membrane enzymes would presumably play two 
very different roles in regulating cellular metabolism. Therefore, they 
would be expected to have significantly different affinities toward the 
same substrate as reflected in the values reported in Table 3. 
Thus, from initial rate studies using both cholera toxin and rabbit 
skeletal muscle transferase, it can be concluded that both enzymes 
catalyze ADP-rlbosylatlon in a manner consistent with a sequential 
mechanism (i.e., products are released from the enzyme only after both 
substrates are bound). The sequential model is described by the 
following rate equation; 
previously reported. The reported V, max value of 0.5 umoles mln"^  mg'^  
V 
,  '^ ia, .  
Vi  (A)(B)  (1) 
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Table 2. Kinetic parameters of cholera toxin 
Km. NAD 
(mM) 
Kj,, ADP-ribose 
acceptor 
(mM) 
(umo$e 
min mg) 
Reference 
1.1 35* 28 (63) 
3.6 0.044b NRC (43) 
NR 75d m (43) 
5.6 39® 0.50 this study 
1.9 17^ 0.051 this study 
®Using agmatine. 
U^sing guany1tyramine. 
®Not reported. 
%sing arginine. 
®Using LAME. 
f Using canavanine. 
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Table'3. Kinetic parameters of endogenous transferases 
Avian Erythrocyte 
Transferase* 
Rabbit Skeletal Muscle 
Transferase 
Km. NAD 
K^ , acceptor 
V, max 
7.0 uM 
0.26 mM 
31 umole 
mln mg 
0.56 mM 
1.2 mM 
40 umole 
mln mg 
*From reference (63) using agmatlne. 
F^rom this study using LAME. 
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C. Inhibitor Studies 
Once it was established that the two enzymes did indeed follow a 
sequential type of mechanism, Inhibitor studies were conducted to 
determine if the mechanisms were random or ordered. The random 
sequential mechanism is depicted in Figure 20 (64). Here, there is no 
obligatory order in which the substrates bind to the enzyme. Compare 
this to the ordered mechanism, shown in Figure 21, where one substrate, 
A, must bind to the enzyme before the second substrate can be bound and 
productive ternary complex formed (64). It was this characteristic of 
the cholera toxin mechanism which seemed to be most refuted In the 
literature. 
As stated earlier Mekalanos reported an ordered mechanism (43) but 
Osborne had reported a random type (63). Neither one of these two 
studies were very convincing. Mekalanos had problems in the initial 
stages of his study because he was not able to obtain Lineweaver-fiurk 
plots that intersected in the same quadrant. Osborne and co-workers 
obtained satisfactory results in the initial stages but did not conduct 
complete inhibition studies. Product inhibition was studied using only 
one product, nicotinamide. An estimate was made as to what extent the 
apparent inhibition constant for nicotinamide depended upon the 
concentration of the acceptor substrate. The choice of random vs. 
ordered was based on whether this factor was or was not equal to 1. 
A more direct method of differentiating between ordered and random 
sequential mechanisms is described by Fromm (64). In this type of study 
Figure 20. Random sequential mechanism scheme. This scheme represents 
a random sequential mechanism for an enzyme (E), two 
substrates (A and B), and two products (P and Q). Adapted 
from reference 64 
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Figure 21. Ordered sequential mechanism. This scheme represents an 
ordered sequential mechanism for an enzyme (E), two substrates 
(A and B), and two products (P and Q). Adapted from reference 
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an investigator is able to determine the type of mechanism based on how 
the initial velocities are affected when specific inhibitors are added to 
the reaction mixture. One of the inhibitors must be competitive toward 
the ADF-ribose donor substrate and the other must be competitive against 
the acceptor substrate. Narayanan attempted these types of inhibition 
studies using substituted (benzylidineamino) guanidine compounds as the 
acceptor substrate (46). However, the solubility of these compounds and 
their apparent inhibition at higher concentrations did not allow 
complete kinetic analyses to be conducted. 
We performed the inhibition studies using the HPLC OPÂ assay 
described earlier. The compound chosen to test against competitiveness 
toward NAD was 3-aminobenzamide. This compound had been used in 
previous studies by other investigators and was shown to be a good 
inhibitor in both mono- and poly-ADP-ribosyl transferase reactions 
(65,66). Figure 22 shows the results obtained for cholera toxin when 
increasing amounts of 3-aminobenzamide were incubated with various 
amounts of NAD and a constant amount of LAME. The results of these same 
experiments using rabbit skeletal muscle transferase are shown in Figure 
23. The convergence of the lines to a single point on the 1/v axis is 
indicative of competitive inhibition toward NAD. Both enzymes exhibited 
the same type of behavior, resulting in a Kj of 35 mM for cholera toxin 
and 14 mM for the rabbit skeletal muscle enzyme. 
A pattern of noncompetitive inhibition was observed when a 
constant amount of NAD was incubated with varying amounts of LAME and 
increasing amounts of 3-aminobenzamide. Noncompetitive inhibition is 
Figure 22. Double reciprocal plot of Initial velocity versus NAD 
concentration at constant 3-amlnobenzamlde concentrations 
using cholera toxin. The reciprocal of the Initial velocities 
at various constant levels of 3-amlnobenzamlde were plotted 
as a function of the reciprocal of NAD concentration. The 
Incubation mixture contained 25 ug/ml of activated cholera 
toxin, 50 mM potassium phosphate pH 7.0, 20 oM DTT, 20 nK 
LAME, and NAD. The 3-amlnobenzamlde concentrations were: 
# 0 mM, A 10 mM, • 20 mM 
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Figure 23. Double reciprocal plot of Initial velocity versus NAD 
concentration at constant 3-amlnobenzamlde concentrations 
using the muscle transferase. The reciprocal of the Initial 
velocities at various constant levels of 3-amlnobenzamlde 
were plotted as a function of the reciprocal of NAD concentration. 
The Incubation mixture contained 5 ug/ml of muscle transferase 
(Con A fraction), 50 mM potassium phosphate pH 7.0, 0.5 mM LAME, 
and NAD. The concentrations of 3 - amlnobenzamlde were: ^  0 mM, 
A 2.5 mM, • 5.0 mM, 1^ 7.5 mM 
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described when the lines resulting from Increased Inhibitor concentration 
converge to a single point which Is not on the 1/v axis. Figures 24 
and 25 show that cholera toxin and rabbit skeletal muscle enzyme 
exhibited this noncompetitive behavior, when Incubated under the 
previously described conditions. 
The search for a competitive inhibitor against the acceptor 
substrate, LAME, was not as straightforward. In order for meaningful 
results to be obtained the double reciprocal plots for increased 
inhibitor concentration must be linear. As shown In Figure 26, when an 
alternate substrate was chosen the double reciprocal plots were not 
linear. The task of finding a competitive inhibitor which was not also a 
substrate proved to be rather formidable. It seemed that any compound 
which contained the guanldino side chain was ADF-rlbosylated. However, 
after testing a number of guanldino derivatives and searching many 
specialty chemical catalogs, a compound called N^ -monomethylarginine was 
found to be distributed by Calbiochem (San Diego, CA). This compound 
seemed to have all the right properties to serve as a competitive 
inhibitor against the acceptor substrate. It contained the guanldino 
side chain which was required for transferase recognition but the active 
site was blocked with a methyl group so it should not have been a 
substrate. The arginine derivative was tested and Indeed was found not 
to be a substrate for the cholera toxin or rabbit transferase. No 
product peak was observed even after prolonged incubation under the 
standard assay conditions, as described under Methods. 
Experiments were conducted in the presence of varied amounts of LAME 
Figure 24. Double reciprocal plot of initial velocity versus LAME 
concentration at constant 3-aminobenzamide concentrations 
using cholera toxin. The reciprocal of the initial velocities 
at various 3 - aminobenzamide concentrations were plotted as a 
function of the reciprocal of LANE concentration. The 
incubation mixtures contained 25 ug/ml of activated cholera 
toxin, 50 mM potassium phosphate pH 7.0, 20 mM DTT, 3.0 mM NAD, 
and LAME. The 3-aminobenzamlde concentrations were: 0 0 mM, 
A 10 mM, # 20 mM 
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Figure 25. Double reciprocal plot of initial velocity versus LAME concentration 
at constant 3-aminobenzamide concentrations using the muscle 
transferase. The reciprocal of the initial velocities at various 
constant concentrations of 3-aminobenzamide were plotted as a 
function of LAME concentration. The incubation mixtures contained 
5 ug/ml muscle transferase (Con A fraction), 50 mM potassium 
phosphate pH 7.0, 0.25 mM HAD, and LAME. The concentrations of 
3-aminobenzamlde were: # 0 mM, A 2.5 mM, @ 5.0 mM, ^ 7.5 mM 
1 / v  ( m i n  p m o l e  - 1 )  
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Figure 26. Double reciprocal plot of initial velocity versus NAD concentration 
at constant DEÀ-BAG concentrations using cholera toxin. The 
reciprocal of the initial velocities at various constant levels 
of DEA.-BAG were plotted as a function of the reciprocal of NAD 
concentration. The incubation mixture contained 25 ug/ml of 
activated cholera toxin, 50 mM potassium phosphate pH 7.0, 20 mH 
DTT, 20 mM LAME, and NAD. The DEA-BAG concentrations were; 
• 0 mM, A 0.5 mM, # 1.0 mM, ^  2.0 mM 
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at constant levels of NAD while increasing the N^ -monomethylarginine 
concentration. The double reciprocal plots obtained for both enzymes 
revealed competitive inhibition toward LAME, as shown in Figures 27 and 
28, for cholera toxin and skeletal muscle transferase, respectively. 
Values of 216 mM and 55 mm were calculated for the Kj of N^ -
monomethylarginine using cholera toxin and rabbit skeletal muscle 
transferase, respectively. When the inhibitor was tested against NAD 
while holding the amount of LAME constant, the results indicated 
noncompetitive inhibition for cholera toxin, as shown in Figure 29, and 
the skeletal muscle transferase, as shown in Figure 30. Fromm has 
developed a scheme for which the type of mechanism may be determined by 
comparing the inhibition patterns against the two different substrates 
(64). This pattern of competitive-noncompetitive inhibition, which was 
demonstrated for both of the inhibitors, is representative of a random 
mechanism. Whereas, an ordered mechanism would have resulted in one of 
the inhibition patterns to be uncompetitive rather than noncompetitive. 
Refer to Figure 20 for an illustration of the random sequential mechanism 
which has been determined to represent the two arglnlne specific ADP-
rlbosyl transferases included in this study. 
D. Specificity Studies Using Alternative Substrates 
In the final phase of this study we evaluated the effect of 
different ADP-ribose acceptors on the Kj^  and of the cholera toxin 
reaction. Several different amino acid derivatives, which differed by 
strategically located substitutions on the side chain or the 
Figure 27. Double reciprocal plot of initial velocity versus LAME concentration 
at constant concentrations of N®-monoinethylarginine using 
cholera toxin. The reciprocal of the Initial velocities at various 
constant levels of N®-monomethylarginine were plotted as a 
function of the reciprocal of LAME concentration. The incubation 
mixtures contained 25 ug/ml of activated cholera toxin, 50 mM 
potassium phosphate pH 7.0, 20 mM DTT, 3.0 mM NAD, and LAME. The 
N®-monomethylarginine concentrations were: 0 0 mM, A 100 mM 
# 300 mM, ^  400 mM 
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Figure 28. Double reciprocal plot of initial velocity versus LAME 
concentration at constant concentrations of N®-monomethylarginine 
using the muscle transferase. The reciprocal of the initial 
velocities at various constant levels of N®-monomethylarginine 
were plotted as a function of the reciprocal of LAME concentration. 
The incubation mixtures contained 5 ug/ml of muscle transferase 
(Con A fraction), 50 mM potassium phosphate pH 7.0, 0.25 mH NAD, 
and LAME. The -monomethylarginine concentrations were: 
# 0 mH, A 10 mM, • 20 mM, 40 mM 
1  / v  ( m i n  p m o l e  - 1 )  
Figure 29. Double reciprocal plot of initial velocity versus NAD concentration 
at constant concentrations of N®-monomethylarginine using 
cholera toxin. The reciprocal of the initial velocities at various 
g 
constant concentrations of N -monomethylarginine were plotted 
versus the reciprocal of NAD concentration. The incubation mixtures 
contained 25 ug/ml of activated cholera toxin, 50 mM potassium 
phosphate pH 7.0, 20 mM DTT, 10 mM LAME, and NAD. The concentrations 
of N^ -monomethylarginine were: # 0 mM, A100 mM, # 200 mM, )^ 400 mM 
1 / v  ( m i n  p m o l e - 1 )  
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Figure 30. Double reciprocal plot of initial velocity versus NAD concentration 
at constant concentrations of N®-monomethylarginine using muscle 
transferase. The reciprocal of the initial velocities at various 
constant concentrations of N®-monomethylarginine were plotted 
as a function of the reciprocal of NAD concentration. The incubation 
mixtures contained 5 ug/ml of muscle transferase (Con A fraction), 
50 mM potassium phosphate pH 7.0, 0.5 mM LAME, and NAD. The 
concentrations of N®-monomethylarginine were: ^  0 mM, 
 ^10 mM, 20 mM, ^ 40 mM 
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carboxylate terminal were studied. These included arginine, arginine 
methyl ester, canavanine, citrulline, and ornithine, whose structures are 
compared in Figure 31. Moss and Vaughan (15) had reported a value for 
arginine of 75 mM with cholera toxin. This resulted in a of 140 
nmole min'^  mg"^ . We have determined the Kg, for arginine methyl ester to 
be 39 mM, with a Vn„ of 500 nmole min'^  mg"^ . The only difference 
between these two substrates is that the carboxylate group on LAME is 
blocked with a methyl ester. This seems to be a somewhat advantageous 
substitution as reflected in the lower and higher of LAME versus 
those of arginine. 
Figures 32 and 33 show the Lineweaver-Burk plots obtained from the 
kinetic studies which utilized canavanine as the ADF-ribose acceptor. A 
sequential mechanism is represented by the convergence of the lines to a 
single common point in the lower left quadrant for both plots. The 
resultant Kj^  value for canavanine was 17 mM with a of 
51 nmole min'^  mg"^ . 
Although the substrates tested thus far are only models for the 
actual cellular target of cholera toxin, they clearly show that the 
enzyme possesses a highly specific catalytic site. The natural target 
for ADP-ribosylation is presumably part of a polypeptide chain where the 
amino and carboxyl terminals participate in amide linkages and therefore, 
are not charged. This specificity was reflected in the nearly ten fold 
increase of the for arginine over that of LAME. Previous studies 
have suggested that the modified amino acid contains a guanidino side 
chain, such as arginine. This was supported by the experiments with 
Figure 31. Comparison of arginine derivatives. and 
values are for cholera toxin 
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Figure 32. Double reciprocal plot of initial velocity versus canavanine 
concentrations at constant NAD concentrations using cholera toxin. 
The reciprocal of the initial velocities at various constant 
concentrations of NAD were plotted as a function of the reciprocal 
of canavanine concentration. The incubation mixtures contained 
25 ug/ml of activated cholera toxin, 50 nM potassium phosphate 
pH 7.0, 20 mM DTT, and canavanine. The NAD concentrations were; 
ilC 1.0 mM, A 1.5 mM, # 2.0 mM, # 5.0 mM 
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Figure 33. Double reciprocal plots of initial velocity versus NAD concentration 
at constant concentrations of canavanlne using cholera toxin. The 
reciprocal of the initial velocities at various constant levels 
of canavanlne were plotted as a function of the reciprocal of NAD 
concentration. The incubation mixtures contained 25 ug/ml of 
activated cholera toxin, 50 mM potassium phosphate pH 7.0, 20 mM 
DTT, and NAD. The canavanlne concentrations were: S 10 mM, 
A 25 mM, # 45 mM 
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basic amino acids such as ornithine and lysine (15), which do not contain 
the guanldino side chain and did not serve as ADP-rlbose acceptors. 
Assays were also performed using citrulline, which contains a ureldo 
rather than a guanldino moiety, as a possible ADP-rlbose acceptor. This 
compound did not prove to be an acceptable substrate for the transferase 
reaction as no product peak was observed even after extensive incubation 
with cholera toxin and NAD. Both citrulline and ornithine were also 
tested for competitive inhibition against LAME, but neither one 
demonstrated any inhibition of the transferase activity even at very 
low concentrations of LAME. These results tell us that the enzyme has a 
very stringent arginine recognition site. 
The final comparison was made between canavanine and arginine. 
Canavanine, like arginine, does not have the carboxyl group blocked which 
resulted in a characteristically low However, the gamma methylene 
group has been replaced by an oxygen which decreases the pK^  of the 
guanidium group to 7 versus 12.5 for arginine (67). At pH 7, the 
guanidium group on canavanine is only partially charged, whereas the side 
chain of arginine is protonated. The net effect of this substitution is 
that canavanine has an even greater binding affinity toward cholera 
toxin, which is reflected in the lower value of 17 mM. This 
phenomenon of decreased with decreased pK^  of the substrate has 
recently been reported for glutathione derivatives with glutathione S-
transferase (68). It has been suggested that an enzyme may utilize part 
of the intrinsic binding energy to deprotonate a substrate. Therefore, 
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a substrate which is already deprotonated would bind more readily than 
one which carried a proton which would result in a lower value. Our 
observations with canavanine support this hypothesis. 
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V. CONCLUSIONS 
A. Summary 
This work has described the development of an assay for arglnlne 
specific AOP-rlbosyl transferases and Its use In determining their 
kinetic mechanisms. Following Is a summary of the results of this study. 
1. The assay does not require a specially synthesized substrate or 
the use of radlolabels. L-arglnlne methyl ester was used as the ÂDP-
rlbose acceptor substrate because it was commercially available and cost 
effective. Derlvatizatlon with an OPA/2-mercaptoethanol reagent, 
separation by HPLC, and fluorescence detection were chosen because of 
their high sensitivity, selectivity, and low background noise. A limit 
of detection of 300 femtomoles was achieved, which proved to be more than 
sufficient for our studies. 
2. Furthermore, the assay proved to be very flexible and reliable. 
The various fractions obtained during the purification of the endogenous 
transferase which contained detergents, exogenous proteins, and other 
possible contaminants were assayed without any problems or Interferences. 
The use of gradient elutlon allowed for rapid sample throughput and 
eliminated the possibility of Interferences in subsequent injections due 
to late eluting peaks. 
3. The assay was used to determine the kinetic parameters of 
cholera toxin and a transferase from rabbit skeletal muscle. Initial 
rate studies were conducted at varying concentrations of one substrate 
and various fixed concentrations of the second substrate. The resulting 
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Llnewëaver-Burk plots were representative of a sequential mechanism for 
both cholera toxin and the rabbit skeletal muscle transferase. This 
result was in agreement with previous reports of a sequential mechanism 
for cholera toxin and a transferase from turkey erythrocytes. 
4. Kinetic parameters were determined from secondary plots of the 
double reciprocal plots and compared with those calculated by a computer 
modeling program. The values of 5.6 mM and 39 mM for NAD and LAME, 
respectively, for cholera toxin were in close agreement with previously 
reported values. Kinetic parameters for the rabbit skeletal muscle 
transferase also were determined. However, these were found to be quite 
different from those reported for the avian transferase. The Kj^  value of 
0.56 mM for NAD is 80 fold higher than that reported for the avian 
enzyme. But, the K^  value for LAME of 1.2 mM was only 6 fold greater 
than the avian transferase. This difference was attributed to the fact 
that the rabbit transferase was purified from a membrane fraction whereas 
the turkey transferase originated from the soluble fraction. It Is 
concluded that there is an intrinsic difference in cellular function and 
specificity for each enzyme which is reflected in the different Kj^  
values. However, the values of 40 umole mln'^  mg"^  for the muscle 
transferase and 31 umoles min*^  mg'^  for the erythrocyte transferase are 
exceptionally close. 
5. Inhibition studies were conducted, with both cholera toxin and 
the rabbit muscle transferase to determine if the sequential mechanisms 
were random or ordered. Competitive inhibitors, which were not 
substrates, were found for both NAD and LAME. The compound 
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S-amlhobenzamlde was found to be competitive against NAD with a of 
35 mH for cholera toxin and 14 mM for the rabbit muscle transferase. It 
was also determined to be noncompetitive against LAME for both enzymes. 
The compound N^ -monomethylarglnlne was found to be competitive against 
LAME with a Kj of 216 mH and 55 mM for cholera toxin and the muscle 
enzyme, respectively. As with the 3-amlnobenzamlde, this Inhibitor was 
found to be noncompetitive against the second substrate with both 
enzymes. This pattern of competltlve-noncompetltlve Inhibition 
demonstrated by both Inhibitors Is indicative of a random mechanism. 
Results from the initial rate studies combined with those from the 
inhibitor studies allowed us to conclude that both enzymes follow a 
random sequential kinetic mechanism. 
6. Finally, specificity studies were conducted using cholera toxin 
with various substrates which were closely related to arglnlne but 
contained significant modifications. Compounds which did not contain the 
guanldlno side chain such as cltrulllne, lysine, and ornithine were not 
recognized as substrates by the enzyme and did not inhibit the 
transferase activity. These results demonstrated the absolute 
requirement of the guanldinium group for substrate recognition. The 
Increased for arglnlne over LAME was attributed to the charged 
carboxylate group which would not be present in the endogenous substrate. 
Canavanine had a relatively low of 17 mM which suggested that the 
substrate must undergo deprotonatlon prior to the catalytic reaction. 
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Although small molecular weight compounds are only models for the 
endogenous substrate, the results clearly show that the enzyme possesses 
a catalytic site which Is highly specific for the substrate. 
B. Suggestions for Future Work 
This work has given us some Insight as to the way arglnlne specific 
ADP-rlbosyl transferases carry out their catalytic activity. But, the 
most ominous question still remains unanswered: what are the functions 
of the transferases in vivo? Many experiments will have to be performed 
to answer this question, not the least of which will be to determine the 
Identity of the endogenous substrate(s). Once the substrates have been 
Identified, the role of ADP-rlbosyl transferases In the regulation of 
cellular metabolism may be established. 
It also will be interesting to leam the similarities and 
differences between the different types of endogenous transferases. 
There is currently no good assay for cysteine specific ADP-rlbosyl 
transferases. We have performed Initial experiments using fluorescent 
cysteine and cystine derivatives as possible substrates but have been 
unable to observe a reaction with pertussis toxin. The development of an 
assay cocktail which contains substrates for both the arglnlne and 
cysteine specific transferases would be a useful tool in screening 
various tissues for these activities. 
I 
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VIII. APPENDIX 
The rate expression given by Equation 1 Is for a Sequential 
mechanism as Illustrated In Figure 12. 
(1) 
V VI(A) VI(B) VI(A)(B) 
Where, v Is the Initial velocity, Vj^  Is the maximal velocity In the 
forward direction, and Ky are the Mlchaells constants, and Is the 
enzyme-substrate dissociation constant. 
When the reciprocal of the Initial velocity Is plotted versus the 
reciprocal of substrate A concentration (Figures 10 and 14), the 
Intercept of Equation (1) Is described by 
Intercept _ . b^ /ox 
Vi Vi(B) 
and the slope of Equation (1) Is described by 
Slope _ Zë + . (3) 
Vi Vi(B) 
When the reciprocal of the initial velocity Is plotted versus the 
reciprocal concentration of the second substrate (Figure 11), 
substitutions of for Ky and A for B are made In Equation 2 and for 
Kg and A for B In Equation 3. 
Secondary plots of Intercepts and slopes versus the reciprocal of 
substrate concentration may then be constructed. When the Intercepts are 
plotted versus the reciprocal of the second substrate concentration, B, 
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(Figures 17 and 19) the Intercept of this plot Is described by 
Intercept _  ^ /A\ 
Vi 
and the slope Is described by 
slope _ fb . (5) 
Vi 
Secondary plots of the slopes versus the reciprocal of the second 
substrate (Figures 16 and 18) are described by 
Intercept _  ^ (g) 
and 
slope _ l^a^ b /y\ 
Vi 
The value of may be calculated from Equation 4 and used In 
Equation 5 to calculate Ky, and In Equation 6 to calculate K^ . The 
values for Ky and may then be used In Equation 7 to calculate 
